111, Inc. Announces $10 Million Share Repurchase Program!!!YI: 111, Inc.
2021-09-07 05:00:00
111, Inc. Announces $10 Million Share Repurchase Program
8110 trade ideas
YI: Bullish PennantBullish Pennant
Pros:
Descending volume during formation
PPS above 50MA and 200MA
RS above 0, and ascending
ATR Ascending
R/R ratio above 7
250RSI above 50
Cons:
200MA flat
Target:
PT = 53.18$
Thank you to those who donate Coins!
Stay Humble, have fun, make money!
Immense volume traded at 23That's a massive volume shelf at 23. Keeping an eye on this. This ticker doesn't have options.
The explosive growth of E-Pharmacy in China We have already witnessed how e-commerce has taken the likes of Alibaba, JD.com, Pinduoduo, Baozun, etc registering strong growth over the past few years in China.
This company, 1 Yaowang is serving a niche market unlike the big boys - Alibaba and JD.com in this e-pharmacy space in China.
Read some articles here and here . I like its Q2 results and due to its small market cap, it is still not a favourite of the institutional players yet.
You can see from chart that there is accumulation between price 5.60-8 dollars range for the last 8 months or so.
I will be initiating a long position tonight.
YI - Ascending TriangleWondering whether this is a bullish Ascending Triangle pattern setting up here and hence time to get long now on any break and then retest of triangle resistance/support?
YI - Bullish Bounce - Can It Recover? RISKY..111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment engages in the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
SHORT INTEREST
32.07K 08/15/19
P/E Current
-1.99
P/E Ratio (with extraordinary items)
-2.73
Average Recommendation: BUY
Average Target Price: 98.42 (Most likely wrong)
YI crab with MACD divergenceCrab looks to have reacted to the PRZ nicely. Also there is a divergence over the entire pattern. Expect price to climb a little higher.
YIMy arrows are purely for educational and visual representation of how i would like the trade to play out for executions. I have no interested in continuing to sell the majors against the USD as we are already so low!!
NASDAQ:YI
